SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-20-012706
Filing Date
2020-11-19
Accepted
2020-11-19 10:57:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 gtbp_424b3.htm 424B3 707481
  Complete submission text file 0001654954-20-012706.txt   708773
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-239858 | Film No.: 201327686
SIC: 2834 Pharmaceutical Preparations